Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

European clinical trial results with irinotecan reported

March 15, 1996

PK1 to enter phase II

March 15, 1996

MEN-10746 selected for development

March 15, 1996

MEN-10755 named as candidate for clinical study

March 15, 1996

Inex reports on liposomal vincristine development

March 15, 1996

Kirin anticancer drug in clinical trials

March 15, 1996

Aminopterin resurrected for ALL

March 15, 1996

University of Bradford reports on cytotoxic indoloquinone

March 15, 1996

Distamycin analogue from P&U shows cytotoxic effects

March 15, 1996

MGI-114 enters phase I

March 15, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...